Momentum Clinical Research
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Momentum Clinical Research - overview
Established
1998
Location
-, -, Australia
Primary Industry
Pharmaceuticals
About
Based in Queensland, Australia, and founded in 1998, Momentum Clinical Research, formerly P3 Research, operates as a clinical trials company offering clinical studies and research services to pharmaceutical companies, contract research organizations, and individual researchers worldwide. In December 2022, Genesis Capital acquired a 90% majority stake in Momentum Clinical Research for USD 8. 8 million. In July 2024, Genesis Capital combined P3 Research Ltd, AusTrials and Holdsworth House Medical Group to form Momentum Clinical Research.
As of February 2025, the company is led by its CEO, Josh Stent. The company also has offices across New Zealand. The company specializes in Phase Ib-IV clinical trials, providing expertise in patient recruitment, research governance, and compliance with Good Clinical Practice (GCP) standards. For participants, the firm offers opportunities to contribute to medical advancements, while for sponsors and CROs, the company provides trial management, ethics approvals, and a patient database for recruitment.
Momentum Clinical Research advances medical science and improves patient outcomes by combining research capabilities. Some of the company’s clients include Pfizer, MSD, Gsk, AstraZeneca.
Current Investors
Genesis Capital
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.momentumclinicalresearch.com/
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Momentum Clinical Research - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Holdsworth House Medical Group | - | ||||||||
| Add-on | Completed | AusTrials | - | ||||||||
| Buyout | Completed | Momentum Clinical Research | - |
Displaying 1 - 3 of 3
Momentum Clinical Research - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.